Global Bone Morphogenetic Protein Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Bone Morphogenetic Protein Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Recombinant Human Bone Morphogenetic Protein (rhBMP) – 2, and Recombinant Human Bone Morphogenetic Protein (rhBMP) -7), Application (Spinal Fusion, Trauma, Reconstructive Surgery, and Oral-maxillofacial), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Bone Morphogenetic Protein Market was valued at USD 548.2 million in 2023 and is expected to reach USD 678.4 million by 2031 while growing at a CAGR of 2.7% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global bone morphogenetic protein Market growth. Morphogenetic proteins, a vital class of signalling molecules, play a crucial role in embryonic development and tissue formation, influencing cell differentiation, proliferation, and pattern formation. Among these proteins, the bone morphogenetic proteins (BMPs) are well-known for their essential role in bone and cartilage development.
The increasing incidence of orthopedic disorders and advancements in biotechnology and medical research are expected to drive substantial growth in the morphogenetic protein market. Despite these positive factors, obstacles such as the high cost of morphogenetic proteins and concerns about side effects and safety may impede market expansion.
Furthermore, the global bone morphogenetic protein industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Bone Morphogenetic Protein Market is segmented among Recombinant Human Bone Morphogenetic Protein (rhBMP) – 2, and Recombinant Human Bone Morphogenetic Protein (rhBMP) -7, based on Type. In 2023, Recombinant Human Bone Morphogenetic Protein (rhBMP) – 2 accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Bone Morphogenetic Protein Market is segmented among Spinal Fusion, Trauma, Reconstructive Surgery, and Oral-maxillofacial, based on Application. In 2023, Spinal Fusion accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Bone Morphogenetic Protein Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Johnson & Johnson, Ember therapeutics Inc., Integra Lifesciences Holdings Corporation, Medtronic PLC, Bio-Techne (R&D Systems, Inc.), Merck KGaA, Pfizer, Inc., Stryker Corporation, Thermo Fischer Scientific, and Zimmer Biomet Holdings, Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Bone Morphogenetic Protein Market Dynamics
Drivers
Restraints
Opportunity
4. Global Morphogenetics Protein Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Bone Morphogenetic Protein Market Segmentation, By Type
Global Bone Morphogenetic Protein Market Share Analysis, By Type
Global Bone Morphogenetic Protein Market Growth Analysis, By Type
Global Bone Morphogenetic Protein Market Trends, By Type
o Recombinant Human Bone Morphogenetic Protein (rhBMP) - 2
o Recombinant Human Bone Morphogenetic Protein (rhBMP) -7
6. Global Bone Morphogenetic Protein Market Segmentation, By Application
Global Bone Morphogenetic Protein Market Share Analysis, By Application
Global Bone Morphogenetic Protein Market Growth Analysis, By Application
Global Bone Morphogenetic Protein Market Trends, By Application
o Spinal Fusion
o Trauma
o Reconstructive Surgery
o Oral-maxillofacial
7. Global Bone Morphogenetic Protein Market Segmentation, By Region
Global Bone Morphogenetic Protein Market Share Analysis, By Region
Global Bone Morphogenetic Protein Market Growth Analysis, By Region
Global Bone Morphogenetic Protein Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
Johnson & Johnson*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Ember Therapeutics Inc.
Integra Lifesciences Holdings Corporation
Medtronic PLC
Bio-Techne (R&D Systems, Inc.)
Merck KGaA
Pfizer, Inc.
Stryker Corporation
Thermo Fischer Scientific
Zimmer Biomet Holdings, Inc.
*Similar analysis will be provided for each company listed above.